Ibuprofen Orifarm

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ibuprofen Orifarm

What is Ibuprofen Orifarm?

Ibuprofen Orifarm is a medicinal product that belongs to a group of drugs known as non-steroidal anti-inflammatory drugs (NSAIDs). The active substance, ibuprofen, is a derivative of propionic acid and is utilized for its properties in managing various conditions characterized by pain and inflammation.

Therapeutic Properties

The medication works by inhibiting the activity of enzymes called cyclooxygenases (COX-1 and COX-2). These enzymes play a central role in the production of prostaglandins, which are chemicals in the body that signal pain and contribute to the inflammatory process. By reducing the synthesis of these substances, Ibuprofen Orifarm provides the following effects:

  • Analgesic: Helps in the reduction of pain.
  • Antipyretic: Assists in lowering elevated body temperatures (fever).
  • Anti-inflammatory: Helps to reduce swelling and inflammation in tissues.

Common Uses

Ibuprofen Orifarm is used for the short-term treatment of mild to moderate acute pain. It is frequently employed for conditions such as:

  • Headaches and migraines.
  • Dental pain.
  • Muscle aches and back pain.
  • Menstrual cramps (dysmenorrhea).
  • Fever associated with common colds or influenza.

Additionally, it may be used for the symptomatic relief of chronic inflammatory conditions, such as rheumatoid arthritis and osteoarthritis, where it helps improve joint mobility by reducing swelling and stiffness.

Regulatory References

  1. MedlinePlus Drug Information on Ibuprofen

What side effects are possible with Ibuprofen Orifarm?

Possible Side Effects and Safety Information

Like all medicines, Ibuprofen Orifarm can cause side effects, although not everybody gets them. Stopping the medication immediately and seeking urgent medical attention is vital if you experience signs of an allergic reaction (e.g., swelling of the face, tongue, or throat; difficulty breathing; severe dizziness; skin rash) or severe skin reactions (e.g., reddening, blistering, or peeling).

Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) and carries a risk of gastrointestinal side effects, including stomach ulcers, perforation, or bleeding, which can be serious and potentially fatal. The risk is higher with prolonged use, high doses, or in elderly patients.

Common Side Effects (May affect up to 1 in 10 people)

  • Gastrointestinal disturbances (e.g., heartburn, indigestion, nausea, vomiting, flatulence, diarrhea, constipation)
  • Headache
  • Dizziness
  • Fatigue

Less Common and Rare Side Effects

Less common effects may include different types of skin rashes and hypersensitivity reactions. Rare, but serious, effects can involve kidney problems, such as acute kidney failure, and liver function disorders. In rare instances, particularly with high doses and long-term treatment, there may be an increased risk of arterial thrombotic events (e.g., heart attack or stroke).

Safety Precautions

Use the lowest effective dose for the shortest duration necessary to control symptoms. Patients with a history of gastrointestinal bleeding or peptic ulcers, heart failure, severe kidney or liver disease, or those taking other NSAIDs or blood thinners, should consult a doctor before use. Pregnant women in the last trimester should not use Ibuprofen Orifarm. Alcohol consumption may increase the risk of gastrointestinal side effects.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory documents define the overdose profile of Ibuprofen Orifarm based on documented clinical manifestations and mandated emergency actions.

Scope of Overdose Regulatory Definition
Documented Manifestations Symptoms may include nausea, vomiting, epigastric pain, severe headache, drowsiness, confusion, and tinnitus.
Severe Outcomes Potential life-threatening outcomes include coma, seizures, acute kidney failure, cardiovascular instability (e.g., hypotension), and gastrointestinal hemorrhage.
Population Notes Elderly patients are at an increased risk for severe gastrointestinal events. Dehydrated children risk renal impairment in overdose scenarios.
Antidote No specific antidote is known. Management is defined as symptomatic and supportive treatment.
Emergency Mandates Required Actions
Immediate Action Required Seek immediate medical attention following any suspected overdose. Contact a Poison Control Center or call local emergency services right away.
Hospital Observation Hospital observation is required because delayed serious complications, such as gastrointestinal bleeding, may manifest several days after exposure.

Official Overdose Statements:

  • Acute kidney failure and metabolic disturbances are documented potential outcomes.
  • Urgent medical help is required when severe symptoms, such as difficulty breathing or loss of consciousness, are present.

The regulatory profile strictly dictates that the presentation of clinical manifestations, particularly those leading to the Severe and Life-Threatening Outcomes, requires immediate emergency response. This mandate ensures the provision of symptomatic and supportive treatment and prolonged monitoring in a hospital setting to address both immediate and delayed systemic risks.

Therapeutic Uses of Ibuprofen Orifarm

Ibuprofen Orifarm is commonly used in situations involving certain distressing symptoms across several key therapeutic domains. The medicine generally helps address symptom clusters that create noticeable physiological strain, contributing to improved comfort during symptomatic fluctuations.

The medicine is relevant in contexts where supportive symptom management is appropriate for conditions presenting with systemic or localized discomfort. It is commonly used to help with the symptoms associated with headache, toothache, fever, muscular aches, and the pain/inflammation of rheumatoid arthritis and osteoarthritis. It is also applied when symptoms interfere with routine activities, such as in cases of primary dysmenorrhea (menstrual cramps) and following minor sprains and strains.

“The primary goal of use is to offer supportive relief during acute manifestations and assist with maintaining functional stability when symptoms escalate temporarily.”

This supportive benefit helps patients cope more steadily with symptom fluctuations, contributing to easing the overall symptom load during difficult episodes.


Quick Fact: Symptomatic Management of Inflammation and Pain


Eligibility and Restrictions for Use

Who Can and Cannot Use Ibuprofen Orifarm?

Eligibility for Ibuprofen Orifarm is defined by regulatory authorities based on age, underlying health conditions, and physiological status. The medicine is contraindicated and must not be used by patients with:

  • Severe Organ Failure: This includes severe heart failure (NYHA Class IV), severe renal failure, or severe hepatic failure.
  • Hypersensitivity History: Patients who have experienced allergic reactions (e.g., asthma, urticaria) after taking aspirin or other NSAIDs.
  • Gastrointestinal Conditions: Individuals with active or a history of recurrent peptic ulcers, haemorrhage, or GI perforation related to previous NSAID therapy.
  • Cardiovascular Surgery: For pain treatment after Coronary Artery Bypass Graft (CABG) surgery.

Eligibility by Population Status

Status Eligibility Rule
Age/Weight Approved for adults and adolescents weighing 40 kg and above (typically ge 12 years). Contraindicated in children under 12 for the standard tablet strengths.
Pregnancy Contraindicated in the third trimester (from 30 weeks gestation). Use requires professional consultation earlier in pregnancy.
Restricted Use Caution is required for elderly patients, those with uncontrolled hypertension, mild-to-moderate heart failure, or pre-existing asthma or mild organ impairment (hepatic or renal).

The official criteria restrict use based on documented risk factors and disease severity, establishing clear boundaries for patient eligibility.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Ibuprofen Orifarm is derived from official regulatory documentation, outlining restrictions and specific effects on clearance and bleeding risk. The profile is primarily defined by the drug's activity as a Non-steroidal Anti-inflammatory Drug (NSAID).


Contraindicated Combinations and Restrictions

Co-administration with other NSAIDs, including cyclooxygenase-2 selective inhibitors, is officially advised against due to a documented increase in the risk of gastrointestinal ulceration and bleeding. The combination with low-dose Acetylsalicylic Acid (Aspirin), used for antiplatelet effect, is generally not recommended, as Ibuprofen may competitively inhibit its intended action. A specific separation rule is mandated: an Ibuprofen dose must be separated by at least 8 hours before or 30 minutes after taking immediate-release low-dose Aspirin [FDA Guidance].

Clearance Modification and Pharmacodynamic Effects

Ibuprofen can reduce the renal clearance of certain medicines, leading to elevated plasma levels. This effect is documented for Lithium and Methotrexate, where reduced clearance may increase the risk of toxicity. Plasma levels of Cardiac Glycosides (like Digoxin) may also increase. The concurrent use of Ibuprofen with Anticoagulants (such as Warfarin), Oral Corticosteroids, or SSRIs may synergistically increase the risk of gastrointestinal bleeding. Ibuprofen can also officially reduce the efficacy of medicines for high blood pressure, including ACE inhibitors and Diuretics.

Non-Medicinal Substances

Consumption of Alcohol (Ethanol) is documented as increasing the risk of gastrointestinal bleeding. Taking the medicine after food is officially recommended to mitigate gastrointestinal undesirable effects [SmPC].

Mechanism of Action

Ibuprofen Orifarm is a non-steroidal anti-inflammatory drug (NSAID) that acts primarily within the enzyme-mediated signaling domain. Its core function is to modulate a key biological pathway responsible for heightened physiological responses.

Targeting Prostanoid Synthesis Pathways

Ibuprofen acts as a non-selective inhibitor of cyclooxygenase (COX) enzymes, specifically targeting both COX-1 and COX-2 isoforms. This mechanism initiates a cascade where the formation of prostaglandins and thromboxanes from arachidonic acid is suppressed. Modifying these early molecular steps within the prostanoid pathway restricts the magnitude of downstream effects resulting from increased mediator activity, resulting in modulations of physiological parameters.


Influencing Regulatory Processes

Inhibiting COX enzymes leads to a marked reduction in the systemic levels of various prostanoids. This effect influences systems where these potent lipid mediators dominate, contributing to shifts in the homeostatic balance of targeted pathways. The suppression of prostanoid signaling modulates overactive signaling associated with specific physiological responses, which are often driven by dysregulated enzyme processes.

Dosage and Administration Information

How to Use Ibuprofen Orifarm

This section outlines the general principles of administering Ibuprofen Orifarm, focusing on the high-level usage patterns.


Administration and Dosage Principles

Ibuprofen Orifarm is intended for oral administration in the form of film-coated tablets. To ensure proper use, tablets must be swallowed whole with water and must not be chewed, crushed, broken, or sucked.

Dosing Schedule: The standard single dose for general use is typically 200 mg or 400 mg. Doses are administered in a divided regimen, usually 3 to 4 times per day, with a minimum interval of 4 to 6 hours between doses to avoid exceeding the daily limit.

Usage Context Daily Dose Range (Adults) Max Daily Dose (Therapeutic)
Short-term / General 1200 mg (Non-Prescription) 1200 mg
Chronic / Anti-inflammatory 1200 mg to 1800 mg 2400 mg

Timing and Duration: Administration should be with or after food for individuals with a sensitive stomach, although taking it on an empty stomach may quicken the onset of action. For acute symptoms, use is strictly short-term. For chronic conditions, such as rheumatic diseases, a longer period of use is required, following the recommended regimen.

Special Population Dosing: The lowest effective dose should be used for the shortest duration necessary in older adults. Furthermore, the higher-strength tablets are generally not recommended for children under 12 years of age due to dosing constraints.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Ibuprofen Orifarm


Evidence for Acute Pain Relief and Fever Reduction

Ibuprofen was evaluated in research exploring conditions associated with acute or disruptive episodes, such as headaches, toothaches, muscular sprains, and fever. Researchers conducted Randomized Controlled Trials (RCTs) and comprehensive meta-analyses that explored short-term symptom changes in both adults and children.

Findings describe patterns observed in studies, reporting measurements of pain intensity and physiological strain (like temperature) over defined time intervals. Research contributes to understanding how symptoms evolved in the observed populations during the study period.

Research has explored the question of whether increases in the amount evaluated beyond a certain point are associated with incremental changes in symptom scores. Follow-up durations were limited to the short-term acute episode, meaning that long-term patterns related to recurrent acute episodes are not extensively characterized.


Evidence for Managing Chronic Inflammatory Conditions (Arthritis)

For conditions marked by functional limitations, such as Osteoarthritis and Rheumatoid Arthritis, Ibuprofen was evaluated in research exploring studies involving adults. The research examined the use of the medicine in controlled trials and observational settings, monitoring outcomes such as changes in daily functioning or activity level.

Studies monitored how symptoms evolved over defined time intervals. However, the evidence for very long-term outcomes (many years) remains limited. Data for certain groups with complex or advanced health conditions remain insufficient.


What Remains Uncertain in the Research Landscape

While many studies contribute to the broader evidence landscape, several areas remain the focus of ongoing review. Findings were sometimes mixed across studies, and evidence quality varies in certain research areas. Crucially, there is limited information for long-term outcomes regarding continuous use over many years for chronic conditions. Research describes group patterns, and does not determine whether an individual will respond similarly, as study results reflect the specific conditions under which they were conducted.

Key Studies & References

  1. IBUPROFEN tablet, film coated - DailyMed (NIH/FDA Drug Label)
  2. Efficacy and safety of ibuprofen and acetaminophen in children and adults: a meta-analysis and qualitative review

Frequently Asked Questions (FAQ)

Common questions about Ibuprofen Orifarm (FAQ)


Q: Is Ibuprofen Orifarm the same as regular Ibuprofen?

The active substance in this product is ibuprofen, which is a single chemical compound classified as an NSAID. The 'Orifarm' name simply identifies the specific manufacturer or marketing authorization holder for this generic version, but the active drug ingredient is chemically identical to that in other ibuprofen products.


Q: What research supports the use of Ibuprofen Orifarm for dental pain?

Research reviewed in official documents has evaluated the use of ibuprofen for conditions associated with acute pain, which includes toothaches. These findings contribute to the general evidence base regarding how the medicine is associated with reducing short-term symptoms.


Q: Can Ibuprofen Orifarm be used for fever reduction?

According to official product information, one of the general therapeutic purposes of ibuprofen is described as providing relief by lowering an elevated body temperature (fever). The medicine is described as having analgesic, anti-inflammatory, and antipyretic (fever-reducing) actions.


Q: Can I take Ibuprofen Orifarm if I have asthma?

Eligibility is restricted for individuals with asthma, as official documents contain warnings for use in patients who have experienced allergic reactions, such as asthma, after taking aspirin or other NSAIDs. Specific caution is required for individuals with pre-existing asthma.


Q: What happens if I forget to take Ibuprofen Orifarm?

Official guidance emphasizes the critical need to maintain the minimum required time interval (such as 4 to 6 hours) between doses. This interval must be maintained to prevent accidentally exceeding the maximum daily dose.


Q: How long does the effect of Ibuprofen Orifarm usually last?

Official drug administration information states that the duration of pain-relieving effects is generally described as being approximately four to six hours.


Q: Is there any risk related to combining Ibuprofen Orifarm with aspirin?

Co-administration with low-dose aspirin is generally not recommended as ibuprofen may interfere with the intended antiplatelet effect of the aspirin. Specific regulatory guidance defines a separation rule between doses (e.g., 8 hours before or 30 minutes after taking immediate-release aspirin).


Q: What is the main reason Ibuprofen Orifarm is prescribed?

The general therapeutic purpose of the medicine is described in regulatory documents as the relief of pain, inflammation, and fever. The official indications cover a range of acute and chronic conditions, including headache, muscular aches, and minor arthritis pain.


Q: How quickly should I expect Ibuprofen Orifarm to start working?

Evidence from product information indicates that the onset of symptom relief is generally described as occurring within 20 to 30 minutes after administration. Peak pain relief effects are typically experienced within one to two hours.


Q: Is Ibuprofen Orifarm known to cause stomach upset?

Gastrointestinal disturbances are listed in official documents as a common side effect. These may include symptoms such as heartburn, indigestion, nausea, or abdominal pain.


Q: Do people often feel dizzy after taking Ibuprofen Orifarm?

Dizziness is listed in official documents as a Common Side Effect. This classification means it may be experienced by a significant number of people, potentially up to 1 in 10, according to official frequency data.


Q: Is it common to see skin reactions listed as a side effect for Ibuprofen Orifarm?

Official documents classify various types of skin rashes and general hypersensitivity reactions as Less Common Side Effects. Separately, severe skin reactions are listed as rare but serious warnings.


Q: Are there specific age limits mentioned for using Ibuprofen Orifarm?

The standard tablet strengths are generally approved for adults and adolescents weighing 40 kg and above (typically 12 years and older). Regulatory documents mandate that caution is specifically required when the medicine is used by elderly patients.


Q: Is there information on using Ibuprofen Orifarm while breastfeeding?

Official research indicates that due to the active substance’s very low levels found in breast milk and its short elimination time (half-life), ibuprofen is often described as compatible with use by nursing mothers.


Q: Is Ibuprofen Orifarm known for causing drowsiness?

Drowsiness (or somnolence) is listed in some official drug documents as a possible adverse event. This is categorized under effects on the central nervous system that may occur in some individuals.


Q: Do official documents mention a maximum duration for using Ibuprofen Orifarm?

Regulatory guidance for over-the-counter use commonly specifies that the duration of use for pain is limited to 5 consecutive days and for fever to 3 days, unless otherwise determined by a health professional.


Q: Why are heart issues sometimes mentioned in relation to Ibuprofen Orifarm?

Official warnings state that NSAIDs, including ibuprofen, may increase the risk of serious arterial thrombotic events (like heart attack or stroke). This risk is especially noted when the medicine is used at higher doses or for longer periods of time.


Q: Is Ibuprofen Orifarm available over-the-counter or is it prescription only?

The medicine is generally available over-the-counter (OTC) up to a maximum daily dose of 1200 mg in many jurisdictions. However, specific higher strengths or regimens intended for chronic conditions typically require a prescription.


Q: Does Ibuprofen Orifarm affect fertility according to research?

Official regulatory documents indicate that medicines which suppress the formation of prostaglandins (like ibuprofen) may impair female fertility by affecting ovulation. This effect is generally described as reversible upon stopping the medicine.


Q: Does the time of day matter when taking Ibuprofen Orifarm?

Official instructions focus primarily on ensuring a sufficient time interval (e.g., 4 to 6 hours) between doses and strictly adhering to the maximum daily limit, rather than specifying an optimal time of day for administration.


Q: What is the difference between Ibuprofen Orifarm and other branded Ibuprofen products?

This product contains the active substance Ibuprofen. While the Orifarm name is associated with the specific generic formulation and manufacturer, the essential active chemical compound is the same as that found in other branded ibuprofen products.


Q: Does the liver process Ibuprofen Orifarm?

Yes, official pharmacokinetic information confirms that the active substance is extensively metabolized (processed) into inactive compounds in the liver. These inactive compounds are then rapidly excreted from the body by the kidneys.


Q: Is it true that Ibuprofen Orifarm can affect blood clotting?

Ibuprofen has a mild, transient effect that can inhibit a key process involved in platelet aggregation (blood clotting). This effect on platelet aggregation is a factor in the documented increased risk of bleeding.


Q: Are there different strengths of Ibuprofen Orifarm available?

Official dose schedules and product information confirm that the film-coated tablets are typically available in different strengths, such as 200 mg and 400 mg, for general use.


Q: Why does the packaging for Ibuprofen Orifarm include a specific warning about the elderly?

The warning is included because older adults have an increased risk for several serious side effects, particularly gastrointestinal bleeding, kidney problems, and heart failure. This is often linked to age-related changes in organ function.


Q: What should I do if a side effect occurs after taking Ibuprofen Orifarm?

Official safety precautions advise seeking urgent medical attention immediately if signs of a severe reaction (like an allergic reaction or internal bleeding) occur. For less severe side effects, regulatory information describes management options which may involve stopping the medicine or seeking consultation.


Q: Are there any known interactions between Ibuprofen Orifarm and herbal supplements?

While specific herbal supplements may not be individually listed in the drug interactions section, official instructions for use generally advise consulting a healthcare professional about all concomitant medicines, which includes herbal remedies and supplements, to manage any potential interaction risk.


Q: What is the general safety profile of Ibuprofen Orifarm according to official sources?

Official summaries describe the medicine as generally having a favorable benefit-risk profile when used as recommended: the lowest effective dose for the shortest duration necessary. Despite this, it carries documented risks for gastrointestinal and cardiovascular adverse events.


Q: What are the listed inactive ingredients in Ibuprofen Orifarm?

The medicine contains the active substance ibuprofen along with solid pharmaceutical excipients (inactive ingredients) that form the tablet's structure and coating. These ingredients are fully listed in the official packaging and product information as required by regulatory bodies.

How should Ibuprofen Orifarm be stored and disposed of?

How to Store and Dispose of Ibuprofen Orifarm?

The storage and disposal of Ibuprofen Orifarm film-coated tablets must strictly follow official regulatory instructions to ensure product quality and safety.


Storage Requirements

Storage Condition Official Requirement
Temperature Store between 20°C and 25°C (68°F and 77°F), or not above 25°C, depending on the formulation.
Protection Keep in the outer carton or original container to protect from light and moisture. Avoid excessive heat above 40°C.
Safety The medicine must be kept out of the sight and reach of children at all times.

Disposal

Expired or unused tablets must not be disposed of in household waste or wastewater. The product must be discarded in accordance with local requirements for pharmaceutical waste, which often involves returning it to a pharmacist or designated collection point.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ibuprofen Orifarm found in:

A-Z Index: